MTORC2 Is required for rit-mediated oxidative stress resistance

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Cai, Weikang ^a   Andres, Douglas A ^a   Reiner, David J ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; HYDROGEN PEROXIDE; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; RIT PROTEIN; STRESS ACTIVATED PROTEIN KINASE 1; UNCLASSIFIED DRUG; MAPKAP1 PROTEIN, HUMAN; MULTIPROTEIN COMPLEX; RAS PROTEIN; RIT1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TARGET OF RAPAMYCIN KINASE; TOR COMPLEX 2;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; IMMUNOPRECIPITATION; IN VITRO STUDY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; ANIMAL; ANIMAL EMBRYO; APOPTOSIS; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; FIBROBLAST; HELA CELL LINE; HUMAN; METABOLISM; PHOSPHORYLATION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; EMBRYO, MAMMALIAN; FIBROBLASTS; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; MICE; MULTIPROTEIN COMPLEXES; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RAS PROTEINS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84919797782     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115602     Document Type: Article

References (41)

1. Finkel T, Holbrook NJ (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408: 239- 247.
2. Wagner EF, Nebreda AR (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9: 537-549.
3. Shi GX, Jin L, Andres DA (2011) A rit GTPase-p38 mitogen-activated protein kinase survival pathway confers resistance to cellular stress. Mol Cell Biol 31: 1938-1948.
4. Manning BD, Cantley LC (2007) AKT/PKB signaling: navigating downstream. Cell 129: 1261-1274.
5. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-1101.
6. Facchinetti V, Ouyang W, Wei H, Soto N, Lazorchak A, et al. (2008) The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. EMBO J 27: 1932-1943.
7. Ikenoue T, Inoki K, Yang Q, Zhou X, Guan KL (2008) Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. EMBO J 27: 1919-1931.
8. Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149: 274-293.
9. Oh WJ, Jacinto E (2011) mTOR complex 2 signaling and functions. Cell Cycle 10: 2305-2316.
10. Liu L, Parent CA (2011) Review series: TOR kinase complexes and cell migration. J Cell Biol 194: 815- 824.
11. Thomanetz V, Angliker N, Cloetta D, Lustenberger RM, Schweighauser M, et al. (2013) Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology. J Cell Biol 201: 293-308.
12. Shi GX, Han J, Andres DA (2005) Rin GTPase couples nerve growth factor signaling to p38 and b-Raf/ERK pathways to promote neuronal differentiation. J Biol Chem 280: 37599-37609.
13. Yang Q, Inoki K, Ikenoue T, Guan KL (2006) Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity. Genes Dev 20: 2820-2832.
14. Schroder WA, Buck M, Cloonan N, Hancock JF, Suhrbier A, et al. (2007) Human Sin1 contains Rasbinding and pleckstrin homology domains and suppresses Ras signalling. Cell Signal 19: 1279-1289.
15. Shi GX, Cai W, Andres DA (2013) Rit subfamily small GTPases: regulators in neuronal differentiation and survival. Cell Signal 25: 2060-2068.
16. Cai W, Rudolph JL, Harrison SM, Jin L, Frantz AL, et al. (2011) An evolutionarily conserved Rit GTPase-p38 MAPK signaling pathway mediates oxidative stress resistance. Molecular biology of the cell 22: 3231-3241.
17. Duran RV, Hall MN (2012) Regulation of TOR by small GTPases. EMBO Rep 13: 121-128.
18. Tatebe H, Morigasaki S, Murayama S, Zeng CT, Shiozaki K (2010) Rab-family GTPase regulates TOR complex 2 signaling in fission yeast. Curr Biol 20: 1975-1982.
19. Saci A, Cantley LC, Carpenter CL (2011) Rac1 regulates the activity of mTORC1 and mTORC2 and controls cellular size. Mol Cell 42: 50-61.
20. Li Y, Inoki K, Vacratsis P, Guan KL (2003) The p38 and MK2 kinase cascade phosphorylates tuberin, the tuberous sclerosis 2 gene product, and enhances its interaction with 14-3-3. J Biol Chem 278: 13663-13671.
21. Cully M, Genevet A, Warne P, Treins C, Liu T, et al. (2010) A role for p38 stress-activated protein kinase in regulation of cell growth via TORC1. Mol Cell Biol 30: 481-495.
22. Zheng M, Wang YH, Wu XN, Wu SQ, Lu BJ, et al. (2011) Inactivation of Rheb by PRAK-mediated phosphorylation is essential for energy-depletion-induced suppression of mTORC1. Nat Cell Biol 13: 263-272.
23. Lee S, Parent CA, Insall R, Firtel RA (1999) A novel Ras-interacting protein required for chemotaxis and cyclic adenosine monophosphate signal relay in Dictyostelium. Mol Biol Cell 10: 2829-2845.
24. Cai H, Das S, Kamimura Y, Long Y, Parent CA, et al. (2010) Ras-mediated activation of the TORC2- PKB pathway is critical for chemotaxis. J Cell Biol 190: 233-245.
25. Loewith R, Jacinto E, Wullschleger S, Lorberg A, Crespo JL, et al. (2002) Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol Cell 10: 457-468.
26. Niles BJ, Joslin AC, Fresques T, Powers T (2014) TOR complex 2-Ypk1 signaling maintains sphingolipid homeostasis by sensing and regulating ROS accumulation. Cell Rep 6: 541-552.
27. Shimada K, Filipuzzi I, Stahl M, Helliwell SB, Studer C, et al. (2013) TORC2 signaling pathway guarantees genome stability in the face of DNA strand breaks. Mol Cell 51: 829-839.
28. Wilkinson MG, Pino TS, Tournier S, Buck V, Martin H, et al. (1999) Sin1: An evolutionarily conserved component of the eukaryotic SAPK pathway. EMBO J 18: 4210-4221.
29. Makino C, Sano Y, Shinagawa T, Millar JB, Ishii S (2006) Sin1 binds to both ATF-2 and p38 and enhances ATF-2-dependent transcription in an SAPK signaling pathway. Genes Cells 11: 1239-1251.
30. Ikeda K, Morigasaki S, Tatebe H, Tamanoi F, Shiozaki K (2008) Fission yeast TOR complex 2 activates the AGC-family Gad8 kinase essential for stress resistance and cell cycle control. Cell Cycle 7: 358-364.
31. Lamming DW, Demirkan G, Boylan JM, Mihaylova MM, Peng T, et al. (2014) Hepatic signaling by the mechanistic target of rapamycin complex 2 (mTORC2). Faseb J 28: 300-315.
32. Berger AH, Imielinski M, Duke F, Wala J, Kaplan N, et al. (2014) Oncogenic RIT1 mutations in lung adenocarcinoma. Oncogene 33: 4418-4423.
33. Cancer Genome Atlas Research N (2014) Comprehensive molecular profiling of lung adeno carcinoma. Nature 511: 543-550.
34. Gomez-Segui I, Makishima H, Jerez A, Yoshida K, Przychodzen B, et al. (2013) Novel recurrent mutations in the RAS-like GTP-binding gene RIT1 in myeloid malignancies. Leukemia 27: 1943-1946.
35. Aoki Y, Niihori T, Banjo T, Okamoto N, Mizuno S, et al. (2013) Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome. Am J Hum Genet 93: 173-180.
36. Bertola DR, Yamamoto GL, Almeida TF, Buscarilli M, Jorge AA, et al. (2014) Further evidence of the importance of RIT1 in Noonan syndrome. Am J Med Genet A 164: 2952-2957.
37. Chen PC, Yin J, Yu HW, Yuan T, Fernandez M, et al. (2014) Next-generation sequencing identifies rare variants associated with Noonan syndrome. Proc Natl Acad Sci U S A 111: 11473-11478.
38. Gos M, Fahiminiya S, Poznanski J, Klapecki J, Obersztyn E, et al. (2014) Contribution of RIT1 mutations to the pathogenesis of Noonan syndrome: four new cases and further evidence of heterogeneity. Am J Med Genet A 164A: 2310-2316.
39. Rusyn EV, Reynolds ER, Shao H, Grana TM, Chan TO, et al. (2000) Rit, a non-lipid-modified Rasrelated protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways. Oncogene 19: 4685-4694.
40. Masui K, Tanaka K, Akhavan D, Babic I, Gini B, et al. (2013) mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and up regulation of c-Myc. Cell Metab 18: 726- 739.
41. Sparks CA, Guertin DA (2010) Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy. Oncogene 29: 3733-3744.